Patrick J. Heron - Jun 1, 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director, 10%+ Owner
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Patrick J. Heron
Stock symbol
ARQT
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 04:53 PM
Previous filing
Jul 20, 2021
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Award $0 +4.31K $0.00 4.31K Jun 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +11.8K $0.00 11.8K Jun 1, 2022 Common Stock 11.8K $20.29 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,312 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
F2 The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022.